🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Brenda L. Jesernig

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab”.

Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001591

N/A

0.547DataRank · unranked

9 citations

Naina Singhi, Brenda L. Jesernig, Kelly G. Paulson, Jonathan Zalevsky, Ernesto Iacucci +3 more

A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells

Journal of Clinical Investigation(2021)10.1172/jci144195

N/A

0DataRank · unranked

28 citations

Naina Singhi, Shivani Srivastava, Julia Szeto, Brenda L. Jesernig, Sylvia M. Stull +6 more

Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

Cancer Cell(2022)10.1016/j.ccell.2022.03.006

N/A

0DataRank · unranked

146 citations

Sylvia M. Lee, Carolyn Shasha, Naina Singhi, Julia Szeto, Ata S. Moshiri +17 more